Chinese Pharmaceutical Start-Up Xgene Raises $20M In Series B Round

Xgene Pharmaceutical, a Shanghai-based pharmaceutical start-up, has raised US$20 million in series B round of financing led by Ping An Ventures.

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Register Now

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!


Already have an account or paid subscription? Log in

China Expert network

LEAVE A REPLY